GLP-1 (glucagon-like peptide-1) receptor agonists are medications originally developed to treat type 2 diabetes and later approved for chronic weight management
Prolonged GLP-1RAs therapy may exacerbate existing chronic inflammation in patients with T2DM, thereby potentially elevating their risk of pancreatic cancer
And the research reveals even more potential benefits for reducing inflammation, supporting the immune system, and improving womens health
Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine , 2021
The convenience of a clinic on Santa Monica Blvd in the heart of West Hollywood cannot be overstated
Manto works closely with Medicare beneficiaries to design personalized medical, nutritional, and resistance-training regimens that ensure safe, muscle-preserving weight loss